Month: February 2022

MENLO PARK, Calif., Feb. 21, 2022 (GLOBE NEWSWIRE) — Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform standards of care and improve patients’ lives, today announced plans to participate in the upcoming Citi Virtual Healthcare Conference. Sight Sciences’ management is scheduled to participate in a fireside chat February 23, 2022, at 8:45am PT. Interested parties may access a live and archived webcast of the fireside chat on the “Investors” section of the company’s website at: https://investors.sightsciences.com/. About Sight SciencesSight Sciences is an eyecare technology company focused on developing and commercializing innovative solutions intended to transform standards of care and improve patients’ lives. Using minimally invasive or non-invasive...

VANCOUVER, British Columbia, Feb. 21, 2022 (GLOBE NEWSWIRE) — Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD6, WKN: A3CSSU) (“Core One” or the “Company”) is pleased to announce that its wholly-owned subsidiary, Vocan Biotechnologies Inc. of Victoria, British Columbia, has filed a patent application with the United States Patent and Trademark Office (“USPTO”) for the production of biosynthetic N-methyltryptamine (NMT) (also known as monomethyl tryptamine (MMT)) through its optimized recombinant production system (the “System”). N-Methyltryptamine is a member of tryptamines and is an organic compound known to produce psychoactive effects when combined with a monoamine oxidase A inhibitor (MAOI).1 The patent entitled “Production of Psychedelic Compounds” protects Core One’s novel proprietary production system. The System,...

Reference is made to the announcement on 12 April 2019, in which Hexagon Composites ASA (the “Company”) announced the provisional award of up to 2,492,438 Performance Share Units (“PSUs”) to senior executives and entitled employees. Each vested PSU will give the holder the right to receive one share in the Company at an exercise price corresponding to the par value of the shares being NOK 0.10. The total program ended at 1,078,628 PSUs of which 299,440 PSUs have been awarded to primary insiders. Please refer to attached forms for further details. The transaction is settled in treasury shares, following which the Company holds 693,270 treasury shares, representing 0.3% of total shares outstanding. To settle the tax obligation resulting from the awarded PSUs, a primary insider has sold some shares. Further details of the primary...

Attached is information regarding a transaction conducted by an entity closely associated with a person discharging managerial responsibilities in relation to the exercise of warrants ICEAIRW180222  Attachments222102 – Möskvi ehf. – Viðskipti222102 – Möskvi ehf – Transaction

Disposal of 6.5% of Mercialys equity by Casino Group  Paris, 21st February 2022, Following the disposal of 3% of Mercialys equity through a total return swap (TRS) concluded on December 6th 2021, and settled on December 22nd 2021, Casino Group completed the additional definitive disposal of 6.5% of Mercialys equity through a new TRS. The Group’s stake in Mercialys in terms of voting rights is reduced from 16.8% to 10.3%. Proceeds of the transaction amount to €59 million. Disclaimer This press release was prepared solely for information purposes, and should not be construed as a solicitation or an offer to buy or sell securities or related financial instruments. Likewise, it does not provide and should not be treated as providing investment advice. It has no connection with the specific investment objectives, financial situation or...

MINNEAPOLIS, Feb. 21, 2022 (GLOBE NEWSWIRE) — Sun Country Airlines (NASDAQ: SNCY) today announced that Dave Davis, President and Chief Financial Officer, will participate in a fireside chat at the 2022 Barclays Industrial Select Conference on February 24, 2022 at 8:35 AM EST. A link to the live webcast can be found on the Sun Country investor relations website at https://ir.suncountry.com/news-events/events-and-presentations. About Sun Country Sun Country Airlines is a new breed of hybrid low-cost air carrier that dynamically deploys shared resources across our synergistic scheduled service, charter and cargo businesses. Based in Minnesota, we focus on serving leisure and visiting friends and relatives (“VFR”) passengers and charter customers and providing CMI service to Amazon, with flights throughout the United States and to...

SAN FRANCISCO and MUNICH, Germany, Feb. 21, 2022 (GLOBE NEWSWIRE) — Lilium N.V. (“Lilium”) (NASDAQ: LILM), announced today that it will crowdsource questions from private shareholders for its upcoming Full Year 2021 business update webcast. Starting today February 21, and continuing through February 27, 2022, retail investors who are current and verified holders of Lilium shares can submit and upvote questions to be reviewed by Lilium’s management team.To submit questions, please visit the Say Connect platform at: http://app.saytechnologies.com/lilium-2021-q4 Retail investors who are not current holders of Lilium shares can submit questions to investors@lilium.com.Lilium will respond to certain questions submitted by registered shareholders through the Say Connect Platform on its Full Year 2021 webcast, which is scheduled...

Nokia CorporationStock Exchange Release21 February 2022 at 21:00 EET Nokia Corporation: Repurchase of own shares on 21.02.2022 Espoo, Finland – On 21 February 2022 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows:Trading venue (MIC Code) Number of shares Weighted average price / share, EUR*XHEL 264,006 4.96CEUX 21,852 4.93AQEU 19,781 4.94TQEX 7,361 4.94Total 313,000 4.95* Rounded to two decimals On 3 February 2022, Nokia announced that its Board of Directors is initiating a share buyback program under the current authorization granted by Nokia’s Annual General Meeting on 8 April 2021 to return up to EUR 600 million of cash to shareholders in traches over a period of two years. The first phase of the share buyback program in compliance with the Market Abuse Regulation...

Collaboration leverages BioNTech’s multi-platform immunotherapy capabilities and Medigene’s T cell receptor (TCR) discovery platform to discover and develop innovative TCR immunotherapies against targets selected by BioNTech BioNTech to acquire preclinical PRAME TCR and receive licenses to Medigene’s PD1-41BB switch receptor and precision pairing technologies BioNTech will hold exclusive worldwide development and commercialization rights to all TCR therapies arising from the collaboration Medigene will receive EUR 26 million upfront from BioNTech, as well as research funding, and will be eligible to receive development, regulatory and commercial milestone payments in addition to royalties and tiered deferred option payments on global net salesMainz/Martinsried/Munich, Germany, February 21, 2022 – BioNTech SE (Nasdaq: BNTX, “BioNTech”)...

LONDON, Feb. 21, 2022 (GLOBE NEWSWIRE) — OKYO Pharma Limited (LSE: OKYO; OTCQB: EMMLF), a biotechnology company focused on the discovery and development of novel molecules to treat inflammatory dry eye diseases and ocular pain, is pleased to announce that it has today issued 403,719,360 new ordinary shares of no par value (“Ordinary Shares“), credited as fully paid on conversion of all outstanding convertible loan notes (“Conversion”) and the cashless exercise of all outstanding warrants, including those resulting from the Conversion. The Company published a prospectus on 5 May 2021 to facilitate the conversion of its then outstanding convertible loan notes and to allow for the issue of the additional shares on the exercise of the warrants that would arise upon the conversion of the convertible loan notes. The 403,719,360...